Literature DB >> 12818421

T-1131-->C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals.

A Horínek, M Vráblík, R Ceska, V Adámková, R Poledne, J A Hubacek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12818421     DOI： 10.1016/s0021-9150(03)00022-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  14 in total

1.  Association of APOA5 Gene Promoter Region -1131T>C Polymorphism (rs662799) to Plasma Triglyceride Level in Patients with Type 2 Diabetic Nephropathy.

Authors:  Abdolkarim Mahrooz; Mehryar Zargari; Vahid Ansari; Atieh Makhlough; Mohammad-Bagher Hashemi-Sooteh
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.

Authors:  Christophe Marçais; Bruno Verges; Sybil Charrière; Valérie Pruneta; Micheline Merlin; Stéphane Billon; Laurence Perrot; Jocelyne Drai; Agnès Sassolas; Len A Pennacchio; Jamila Fruchart-Najib; Jean-Charles Fruchart; Vincent Durlach; Philippe Moulin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents.

Authors:  D D V Brito; A P Fernandes; K B Gomes; F F Coelho; N G Cruz; A P Sabino; J E Cardoso; P P Figueiredo-Filho; R Diamante; C R Norton; M O Sousa
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

4.  -1131T>C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients.

Authors:  Mirelle O Sóter; Karina B Gomes; Ana P Fernandes; Maria das G Carvalho; Poliana S Pinheiro; Adriana A Bosco; Daniel D R Silva; Marinez O Sousa
Journal:  Mol Biol Rep       Date:  2012-02-19       Impact factor: 2.316

5.  Apolipoprotein AV gene polymorphisms (T-1131/C and Ser19/Trp) influence plasma triglyceride levels and risk of myocardial infarction.

Authors:  Jaroslav A Hubacek; Zdena Skodova; Vera Adamkova; Michal Vrablik; Ales Horinek; Vera Lanska; Richard Ceska; Rudolf Poledne
Journal:  Exp Clin Cardiol       Date:  2003

6.  APOAV (T-1131>C) variant has no effect on mother's height in a large population study.

Authors:  Jaroslav A Hubacek; Zdena Skodova; Vera Adamkova; Vera Lanska; Dagmar Bobkova; Rudolf Poledne
Journal:  Lipids Health Dis       Date:  2004-05-24       Impact factor: 3.876

7.  Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis.

Authors:  Pirkka-Pekka Laurila; Jussi Naukkarinen; Kati Kristiansson; Samuli Ripatti; Tuuli Kauttu; Kaisa Silander; Veikko Salomaa; Markus Perola; Pekka J Karhunen; Philip J Barter; Christian Ehnholm; Leena Peltonen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

8.  The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.

Authors:  Yangsoo Jang; Jean Kyung Paik; Yae Jung Hyun; Jey Sook Chae; Ji Young Kim; Ju Ree Choi; Sang Hak Lee; Dong-Jik Shin; Jose M Ordovas; Jong Ho Lee
Journal:  Clin Chim Acta       Date:  2008-12-31       Impact factor: 3.786

9.  Overexpression of apolipoprotein A5 in mice is not protective against body weight gain and aberrant glucose homeostasis.

Authors:  Nathalie Pamir; Timothy S McMillen; Yu-I Li; Ching-Mei Lai; Howard Wong; Renée C LeBoeuf
Journal:  Metabolism       Date:  2009-04       Impact factor: 8.694

10.  Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels.

Authors:  Rui-Xing Yin; Yi-Yang Li; Wan-Ying Liu; Lin Zhang; Jin-Zhen Wu
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.